原代细胞市场，规模，占有率，趋势，产业分析报告:来源，各类型，各用途，各终端用户，各地区 - 2025年～2034年的市场预测

根据 Polaris Market Research 的最新研究，预计到 2034 年，原代细胞市场规模将达到 49.5 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

原代细胞是分离的细胞，保留了其来源组织的生理特性，这对于建构逼真的生物模型具有重要价值。这些细胞越来越多地融入个人化医疗，其能够重现患者特定状况，从而支持客製化治疗策略，这正在推动成长机会。这一趋势正在透过提高药物反应预测的准确性和降低副作用风险来改变药物的发现和开发。随着医疗保健朝着更精准和个人化的解决方案发展，原代细胞在连接实验室研究和临床结果方面发挥关键作用。

细胞培养技术的快速发展提高了这些细胞在研究和治疗方面的实用性、稳定性和可扩展性。近期的创新，例如3D培养系统、先进的共培养方法和自动化技术，正在提高原代细胞研究的有效性和可重复性。这些进步解决了原代细胞寿命短和多变性等传统局限性，同时为再生医学、疾病建模和毒性测试开闢了新的途径。因此，原代细胞正成为下一代生物医学研究和治疗开发的重要工具。

原代细胞市场报告重点

按来源划分，人体来源部门市场将在2024年占69.38%的主导收入占有率，这得益于其在精确模拟人体生物过程方面具有卓越的生理相关性。

按类型划分，肝细胞部门市场预计将以12.6%的复合年增长率增长，这得益于肝细胞在药物代谢和毒性测试中的重要作用。

到2024年，北美将以51.46%的市占率引领全球市场，这得益于其先进的医疗基础设施和强大的生物製药研发部门。

预计亚太市场将以13.1%的最高复合年增长率成长，这得益于生物医学科学投资的增加和製药製造业的扩张。

全球主要市场参与者包括 ALLCells、Axol Bioscience Ltd、Cell Applications, Inc、Cell Biologics, Inc、Creative Bioarray、Cureline、Lonza Group, AG、Merck KGaA、Pelobiotech、PromoCell、Sigma-Aldrich、Stem Cell Technologies、Thermo Fisher Scient Technologies Inc., ZenrBio.

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 原代细胞市场洞察

• 原代细胞 - 产业概述
• 原代细胞市场动态
  • 促进因素和机会
    • 慢性病发生率上升和癌症
    • 细胞培养技术与研究工具的进展
    • 2024 年主要资助计画范例
    • 全球资助类型（按年份）
    • 不断扩大的全球临床格局
    • 不断扩展的细胞培养技术应用组合
    • 疫苗生产、人工器官、培养基和生物製药的需求不断增长
  • 阻碍因素和课题
    • 可扩充性问题
    • 关于动物的伦理问题
• 波特五力模型分析
  • 供应商议价能力（中）
  • 新进入者的威胁（低）
  • 买方议价能力（中）
  • 替代品的威胁（中）
  • 现有企业之间的竞争（高）
• PEST 分析
• COVID-19 影响分析及产业趋势

第5章 原代细胞市场评估:来源

• 简介
• 动物来源
• 人来源

第6章 原代细胞市场评估:各类型

• 简介
• 造血
• 肝细胞
• 肾细胞
• 消化管细胞
• 皮肤细胞
• 肺细胞
• 其他的类型

第7章 原代细胞市场评估:各用途

• 简介
• ADME毒性实验
• 其他用途

第8章 原代细胞市场评估:各终端用户

• 简介
• 製药·生物科技企业
• 研究机关

第9章 原代细胞市场评估:各地区

• 简介
• 北美
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
• 南美
  • 巴西
  • 墨西哥
• 中东·非洲

第10章 竞争情形

• 产品发布是企业最常使用的策略
• 产品销售
• 联盟/合作/协定/公开

第11章 企业简介

• Cell Biologics, Inc.
• ZenBio, Inc.
• Stem Cell Technologies
• Sigma-Aldrich
• Thermo Fisher Scientific
• Cureline
• American Type Culture Collection
• Cell Applications, Inc.
• Pelobiotech
• Merck KGaA
• Axol Bioscience Ltd
• PromoCell
• ALLCells
• Lonza Group, AG
• Creative Bioarray

The primary cells market size is expected to reach USD 4.95 billion by 2034, according to a new study by Polaris Market Research. The report "Primary Cells Market Share, Size, Trends, Industry Analysis Report: By Source, By Type (Animal Source, Human Source), By Application, By End Users, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Primary cells are isolated cells that retain the physiological properties of their tissue of origin, making them highly valuable for creating realistic biological models. The growing integration of these cells in personalized medicine, where their ability to replicate patient-specific conditions supports tailored therapeutic strategies, drives the growth opportunities. This trend is reshaping drug discovery and development by improving accuracy in predicting drug responses and reducing the risks of adverse effects. Primary cells are playing a critical role in bridging laboratory research with clinical outcomes as healthcare moves towards more precise and individualized solutions.

The rapid advancement of cell culture technologies has enhanced the utility, stability, and scalability of these cells for research and therapeutic purposes. Modern innovations such as 3D culture systems, advanced co-culture methods, and automation have improved the relevance and reproducibility of studies involving primary cells. These advancements address the traditional limitations of short lifespan and variability and also open new avenues in regenerative medicine, disease modeling, and toxicology testing. As a result, primary cells are becoming essential tools for next-generation biomedical research and therapy development.

Primary Cells Market Report Highlights

In terms of source, the human source segment held a dominant 69.38% revenue share in 2024, owing to its superior physiological relevance for accurately modeling human biological processes.

Based on type, the hepatocytes segment is projected to grow at the fastest CAGR of 12.6%, driven by their critical role in drug metabolism and toxicity testing.

North America led the global market with a 51.46% share in 2024, attributed to its advanced healthcare infrastructure and robust biopharmaceutical R&D sector.

The Asia Pacific market is expected to grow at the highest CAGR of 13.1%, propelled by rising biomedical investments and expanding pharmaceutical manufacturing.

A few global key market players include ALLCells; Axol Bioscience Ltd; Cell Applications, Inc.; Cell Biologics, Inc.; Creative Bioarray; Cureline; Lonza Group, AG; Merck KGaA; Pelobiotech; PromoCell; Sigma-Aldrich; Stem Cell Technologies; Thermo Fisher Scientific; and ZenBio, Inc.

Polaris Market Research has segmented the market report on the basis of source, type, application, end users, and region:

By Source Outlook (Revenue, USD Billion, 2020-2034)

Animal Source

Human Source

By Type Outlook (Revenue, USD Billion, 2020-2034)

Hematopoietic

Hepatocytes

Renal Cells

Gastrointestinal Cells

Skin Cells

Lung Cells

Other Types

By Application Outlook (Revenue, USD Billion, 2020-2034)

ADME Toxicology Testing

Other Applications

By End Users Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical & Biotechnology Companies

Research Institutes

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

Chapter 1. Introduction

• 1.1 Report Description
  • 1.1.1 Objectives of the Study
  • 1.1.2 Market Scope
  • 1.1.3 Assumptions
• 1.2 Stakeholders

Chapter 2. Executive Summary

Chapter 3. Research Methodology

• 3.1 Overview
  • 3.1.1 Data Mining
• 3.2 Data Sources
  • 3.2.1 Primary Sources
  • 3.2.2 Secondary Sources

Chapter 4. Primary Cells Market Insights

• 4.1 Primary Cells - Industry snapshot
• 4.1 Primary Cells Market Dynamics
  • 4.1.1 Drivers and Opportunities
    • 4.1.1.1 Rising Prevalence of Chronic Diseases and Cancer
    • 4.1.1.2 Advancements in Cell Culture Technologies and Research Tools
    • 4.1.1.2.1 Examples of key financing initiatives, 2024
    • 4.1.1.2.2 Total Global Financings Type by Year
    • 4.1.1.2.3 Widening Global Clinical Landscape
    • 4.1.1.3 Widening Application Portfolio Of Cell Culture Technology
    • 4.1.1.4 Rising Demand For Vaccine Production, Artificial Organs, Media, and Biopharmaceuticals
  • 4.1.2 Restraints and Challenges
    • 4.1.2.1 Scalability Issues
    • 4.1.2.2 Ethical Concerns Pertaining To Animals
• 4.2 Primary Cells Market - Porter's Five Forces
  • 4.2.1 Bargaining Power of Suppliers (Moderate)
  • 4.2.2 Threats of New Entrants: (Low)
  • 4.2.3 Bargaining Power of Buyers (Moderate)
  • 4.2.4 Threat of Substitute (Moderate)
  • 4.2.5 Rivalry among existing firms (High)
• 4.3 Primary Cells Market - PEST Analysis
• 4.4 Covid-19 Impact Analysis & Industry Trends

Chapter 5. Primary Cells Market Assessment by Source

• 5.1 Introduction
• 5.2 Animal Source
• 5.3 Human Source

Chapter 6. Primary Cells Market Assessment by Type

• 6.1 Introduction
• 6.2 Hematopoietic
• 6.3 Hepatocytes
• 6.4 Renal Cells
• 6.5 Gastrointestinal Cells
• 6.6 Skin Cells
• 6.7 Lung Cells
• 6.8 Other Types

Chapter 7. Hepatocytes Market Assessment by Application

• 7.1 Introduction
• 7.2 ADME Toxicology Testing
• 7.3 Other Applications

Chapter 8. Primary Cells Market Assessment by End-Users

• 8.1 Introduction
• 8.2 Pharmaceutical & Biotechnology Companies
• 8.3 Research Institutes

Chapter 9. Primary Cells Market Assessment by Region

• 9.1 Introduction
• 9.2 Primary Cells Market - North America
  • 9.2.1 Primary Cells Market - U.S.
  • 9.2.2 Primary Cells Market - Canada
• 9.3 Primary Cells Market - Europe
  • 9.3.1 Primary Cells Market - Germany
  • 9.3.2 Primary Cells Market - UK
  • 9.3.3 Primary Cells Market - France
  • 9.3.4 Primary Cells Market - Italy
• 9.4 Primary Cells Market - Asia Pacific
  • 9.4.1 Primary Cells Market - China
  • 9.4.2 Primary Cells Market - India
  • 9.4.3 Primary Cells Market - Japan
  • 9.4.4 Primary Cells Market - South Korea
• 9.5 Primary Cells Market - Latin America
  • 9.5.1 Primary Cells Market - Brazil
  • 9.5.2 Primary Cells Market - Mexico
• 9.6 Primary Cells Market - Middle East & Africa

Chapter 10. Competitive Landscape

• 10.1 Product Launch is the Best Adopted Strategy by the Companies
• 10.2 Product Launch
• 10.3 Partnerships/Collaborations/Agreements/Exhibitions

Chapter 11. Company Profiles

• 11.1 Cell Biologics, Inc.
  • 11.1.1 Business Overview
  • 11.1.2 Financial Snapshot
  • 11.1.3 Products and Services
• 11.2 ZenBio, Inc.
  • 11.2.1 Business Overview
  • 11.2.2 Financial Snapshot
  • 11.2.3 Products and Services
• 11.3 Stem Cell Technologies
  • 11.3.1 Business Overview
  • 11.3.2 Financial Snapshot
  • 11.3.3 Products and Services
  • 11.3.4 Recent Developments
• 11.4 Sigma-Aldrich
  • 11.4.1 Business Overview
  • 11.4.2 Financial Snapshot
  • 11.4.3 Products and Services
  • 11.4.4 Recent Developments
• 11.5 Thermo Fisher Scientific
  • 11.5.1 Business Overview
  • 11.5.2 Financial Snapshot
  • 11.5.3 Products and Services
  • 11.5.4 Recent Developments
• 11.6 Cureline
  • 11.6.1 Business Overview
  • 11.6.2 Financial Snapshot
  • 11.6.3 Products and Services
  • 11.6.4 Recent Developments
• 11.7 American Type Culture Collection
  • 11.7.1 Business Overview
  • 11.7.2 Financial Snapshot
  • 11.7.3 Products and Services
  • 11.7.4 Recent Developments
• 11.8 Cell Applications, Inc.
  • 11.8.1 Business Overview
  • 11.8.2 Financial Snapshot
  • 11.8.3 Products and Services
• 11.9 Pelobiotech
  • 11.9.1 Business Overview
  • 11.9.2 Financial Snapshot
  • 11.9.3 Products and Services
  • 11.9.4 Recent Developments
• 11.10 Merck KGaA
  • 11.10.1 Business Overview
  • 11.10.2 Financial Snapshot
  • 11.10.3 Products and Services
  • 11.10.4 Recent Developments
• 11.11 Axol Bioscience Ltd
  • 11.11.1 Business Overview
  • 11.11.2 Financial Snapshot
  • 11.11.3 Products and Services
  • 11.11.4 Recent Developments
• 11.12 PromoCell
  • 11.12.1 Business Overview
  • 11.12.2 Financial Snapshot
  • 11.12.3 Products and Services
  • 11.12.4 Recent Developments
• 11.13 ALLCells
  • 11.13.1 Business Overview
  • 11.13.2 Financial Snapshot
  • 11.13.3 Products and Services
  • 11.13.4 Recent Developments
• 11.14 Lonza Group, AG
  • 11.14.1 Business Overview
  • 11.14.2 Financial Snapshot
  • 11.14.3 Products and Services
  • 11.14.4 Recent Developments
• 11.15 Creative Bioarray
  • 11.15.1 Business Overview
  • 11.15.2 Financial Snapshot
  • 11.15.3 Products and Services

List of Tables

• Table 1 Global Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 1 Global Primary Cells Market, by Animal Source, 2020 - 2034 (USD Billion)
• Table 2 Global Primary Cells Market, by Human Source, 2020 - 2034 (USD Billion)
• Table 3 Global Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 4 Global Primary Cells Market, by Hematopoietic, 2020 - 2034 (USD Billion)
• Table 5 Global Primary Cells Market, by Hepatocytes, 2020 - 2034 (USD Billion)
• Table 6 Global Primary Cells Market, by Renal Cells, 2020 - 2034 (USD Billion)
• Table 7 Global Primary Cells Market, by Gastrointestinal Cells, 2020 - 2034 (USD Billion)
• Table 8 Global Primary Cells Market, by Skin Cells, 2020 - 2034 (USD Billion)
• Table 9 Global Primary Cells Market, by Lung Cells, 2020 - 2034 (USD Billion)
• Table 10 Global Primary Cells Market, by Other Types, 2020 - 2034 (USD Billion)
• Table 11 Global Hepatocytes Market Assessment, by Application, 2020 - 2034 (USD Billion)
• Table 12 Global Hepatocytes Market, by ADME Toxicology Testing, 2020 - 2034 (USD Billion)
• Table 13 Global Hepatocytes Market, by Other Applications, 2020 - 2034 (USD Billion)
• Table 14 Global Primary Cells Market, By End-Users, 2020 - 2034 (USD Billion)
• Table 15 Global Primary Cells Market, by Pharmaceutical & Biotechnology Companies, 2020 - 2034 (USD Billion)
• Table 16 Global Primary Cells Market, by Research Institutes, 2020 - 2034 (USD Billion)
• Table 17 Primary Cells Market Assessment, By Geography, 2020 - 2034 (USD Billion)
• Table 18 North America Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 19 North America Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 20 North America Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 21 North America Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 22 U.S. Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 23 U.S. Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 24 U.S. Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 25 U.S. Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 26 Canada Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 27 Canada Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 28 Canada Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 29 Canada Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 30 Europe Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 31 Europe Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 32 Europe Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 33 Europe Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 34 Germany Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 35 Germany Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 36 Germany Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 37 Germany Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 38 UK Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 39 UK Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 40 UK Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 41 UK Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 42 France Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 43 France Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 44 France Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 45 France Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 46 Italy Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 47 Italy Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 48 Italy Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 49 Italy Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 50 Asia Pacific Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 51 Asia Pacific Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 52 Asia Pacific Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 53 Asia Pacific Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 54 China Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 55 China Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 56 China Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 57 China Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 58 India Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 59 India Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 60 India Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 61 India Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 62 Japan Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 63 Japan Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 64 Japan Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 65 Japan Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 66 South Korea Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 67 South Korea Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 68 South Korea Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 69 South Korea Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 70 Latin America Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 71 Latin America Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 72 Latin America Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 73 Latin America Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 74 Brazil Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 75 Brazil Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 76 Brazil Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 77 Brazil Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 78 Mexico Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 79 Mexico Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 80 Mexico Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 81 Mexico Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 82 Middle East & Africa Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 83 Middle East & Africa Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 84 Middle East & Africa Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 85 Middle East & Africa Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)

List of Figures

• Figure 1. Executive Summary
• Figure 2. Research Methodology: Top Down & Bottom-Up Approach
• Figure 3. Market by Geography
• Figure 4. Total Clinical Trials Underway in 2024
• Figure 5. Porter's Five Forces
• Figure 6. Primary Cells Market - PEST Analysis
• Figure 7. Market by Source
• Figure 8. Global Primary Cells Market, By Source, 2024 & 2034 (USD Billion)
• Figure 9. Market by Type
• Figure 10. Global Primary Cells Market, By Type, 2024 & 2034 (USD Billion)
• Figure 11. Market by Application
• Figure 12. Global Hepatocytes Market Assessment, by Application, 2024 & 2034 (USD Billion)
• Figure 13. Market by End-Users
• Figure 14. Global Primary Cells Market, By End-Users, 2024 & 2034 (USD Billion)
• Figure 15. Primary Cells Market Assessment, By Geography, 2024 & 2034 (USD Billion)
• Figure 16. Strategic Analysis - Primary Cells